ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary.

Andrea Cavazzoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.